Wednesday Jun 29, 2022
Wednesday Jun 29, 2022

Russia-developed COVID-19 drug to start production in December- Firm to Sputnik


Nepalnews
2021 Nov 13, 18:38, Moscow
Representative Image (photo via ANI)

The production of the Favipiravir antiviral drug that will be used in COVID-19 vaccines will commence in December, the press service of the Russian pharmaceutical company Promomed told Sputnik.

"Production will start in December," a Promomed spokesperson said.

On November 12, the drug was registered as a means to treat COVID-19 through vaccinations. It will be put into circulation for the next 5 years.

The drug was approved by Russia's health ministry to be developed into pills in 2020 and sold under the name of Areplivir to treat COVID-19 infections. Its chemical base was initially developed by Japanese company Fujifilm Holdings Corp as an influenza drug.

READ ALSO:

russia covid-19 drug production Sputnik COVID vaccine COVID vaccines Influenza Drug Areplivir Favipiravir antiviral drug
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

KMC-02, UttarDhoka,
Lazimpat, Nepal

Newsroom
+977–01–4445751 / 4445754

E-mail
[email protected] [email protected]

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal